Your browser doesn't support javascript.
loading
Drug Dissolution in Oral Drug Absorption: Workshop Report.
Raines, Kimberly; Agarwal, Payal; Augustijns, Patrick; Alayoubi, Alaadin; Attia, Lucas; Bauer-Brandl, Annette; Brandl, Martin; Chatterjee, Parnali; Chen, Hansong; Yu, Yuly Chiang; Coutant, Carrie; Coutinho, Ana Luisa; Curran, David; Dressman, Jennifer; Ericksen, Bryan; Falade, Leah; Gao, Yi; Gao, Zongming; Ghosh, Debasis; Ghosh, Tapash; Govada, Anitha; Gray, Elizabeth; Guo, Ruiqiong; Hammell, Dana; Hermans, Andre; Jaini, Rohit; Li, Hanlin; Mandula, Haritha; Men, Shuaiqian; Milsmann, Johanna; Moldthan, Huong; Moody, Rebecca; Moseson, Dana E; Müllertz, Anette; Patel, Roshni; Paudel, Kalpana; Reppas, Christos; Savkur, Rajesh; Schaefer, Kerstin; Serajuddin, Abu; Taylor, Lynne S; Valapil, Rutu; Wei, Kevin; Weitschies, Werner; Yamashita, Shinji; Polli, James E.
Afiliação
  • Raines K; Food and Drug Administration, Center for Drug Evaluation and Research, White Oak, Maryland, USA.
  • Agarwal P; Food and Drug Administration, Center for Drug Evaluation and Research, White Oak, Maryland, USA.
  • Augustijns P; Department of Pharmaceutical and Pharmacological Sciences, University of Leuven, ON2 Herestraat 49-Box 921, 3000, Leuven, Belgium.
  • Alayoubi A; Food and Drug Administration, Center for Drug Evaluation and Research, White Oak, Maryland, USA.
  • Attia L; Massachusetts Institute of Technology, 77 Massachusetts Ave, Cambridge, Massachusetts, 02139, USA.
  • Bauer-Brandl A; University of Southern Denmark, Campusvej 55, 5230, Odense, Denmark.
  • Brandl M; University of Southern Denmark, Campusvej 55, 5230, Odense, Denmark.
  • Chatterjee P; Food and Drug Administration, Center for Drug Evaluation and Research, White Oak, Maryland, USA.
  • Chen H; Food and Drug Administration, Center for Drug Evaluation and Research, White Oak, Maryland, USA.
  • Yu YC; University of Maryland School of Pharmacy, Baltimore, Maryland, USA.
  • Coutant C; Eli Lilly and Company, 893 Delaware St, Indianapolis, Indiana, 46225, USA.
  • Coutinho AL; University of Maryland School of Pharmacy, Baltimore, Maryland, USA.
  • Curran D; GlaxoSmithKline, 1250 S. Collegeville Road, Collegeville, Pennsylvania, 19046, USA.
  • Dressman J; Fraunhofer Institute of Translational Pharmacology and Medicine, Theodor-Stern-Kai 7, 60596, Frankfurt am Main, Germany.
  • Ericksen B; Food and Drug Administration, Center for Drug Evaluation and Research, White Oak, Maryland, USA.
  • Falade L; Food and Drug Administration, Center for Drug Evaluation and Research, White Oak, Maryland, USA.
  • Gao Y; AbbVie Inc, 1 North Waukegan Road, North Chicago, Illinois, 60064, USA.
  • Gao Z; Food and Drug Administration, Center for Drug Evaluation and Research, St. Louis, Missouri, USA.
  • Ghosh D; Food and Drug Administration, Center for Drug Evaluation and Research, White Oak, Maryland, USA.
  • Ghosh T; Food and Drug Administration, Center for Drug Evaluation and Research, White Oak, Maryland, USA.
  • Govada A; Food and Drug Administration, Center for Drug Evaluation and Research, White Oak, Maryland, USA.
  • Gray E; Food and Drug Administration, Center for Drug Evaluation and Research, White Oak, Maryland, USA.
  • Guo R; Takeda Pharmaceuticals, 650 E Kendall St, Cambridge, Massachusetts, 02142, USA.
  • Hammell D; University of Maryland School of Pharmacy, Baltimore, Maryland, USA.
  • Hermans A; Merck & Co. Inc., 2025 E Scott Ave, Rahway, New Jersey, 07065, USA.
  • Jaini R; Pfizer Inc., 1 Portland St, Cambridge, Massachusetts, 02139, USA.
  • Li H; Vertex Pharmaceuticals, 50 Northern Ave, Boston, Massachusetts, 02210, USA.
  • Mandula H; Food and Drug Administration, Center for Drug Evaluation and Research, White Oak, Maryland, USA.
  • Men S; University of Maryland School of Pharmacy, Baltimore, Maryland, USA.
  • Milsmann J; Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400, Biberach an der Riss, Germany.
  • Moldthan H; Food and Drug Administration, Center for Drug Evaluation and Research, White Oak, Maryland, USA.
  • Moody R; Food and Drug Administration, Center for Drug Evaluation and Research, White Oak, Maryland, USA.
  • Moseson DE; Pfizer Inc., 558 Eastern Point Rd., Groton, Connecticut, 06340, USA.
  • Müllertz A; University of Copenhagen, Nørregade 10, 1165, København, Denmark.
  • Patel R; University of Maryland School of Pharmacy, Baltimore, Maryland, USA.
  • Paudel K; Food and Drug Administration, Center for Drug Evaluation and Research, White Oak, Maryland, USA.
  • Reppas C; National and Kapodistrian University of Athens, 157 72, Athens, Greece.
  • Savkur R; Food and Drug Administration, Center for Drug Evaluation and Research, White Oak, Maryland, USA.
  • Schaefer K; Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400, Biberach an der Riss, Germany.
  • Serajuddin A; Department of Pharmaceutical Sciences, St John's University, 8000 Utopia Parkway, Queens, New York, USA.
  • Taylor LS; Purdue University, 610 Purdue Mall, West Lafayette, Indiana, 47907, USA.
  • Valapil R; University of Maryland School of Pharmacy, Baltimore, Maryland, USA.
  • Wei K; Food and Drug Administration, Center for Drug Evaluation and Research, White Oak, Maryland, USA.
  • Weitschies W; University of Greifswald, Domstraße 11, 17489, Greifswald, Germany.
  • Yamashita S; Ritsumeikan University, 56-1 Tojiin Kitamachi, Kita Ward, Kyoto, 603-8577, Japan.
  • Polli JE; University of Maryland School of Pharmacy, Baltimore, Maryland, USA. jpolli@rx.umaryland.edu.
AAPS J ; 25(6): 103, 2023 11 07.
Article em En | MEDLINE | ID: mdl-37936002
The in-person workshop "Drug Dissolution in Oral Drug Absorption" was held on May 23-24, 2023, in Baltimore, MD, USA. The workshop was organized into lectures and breakout sessions. Three common topics that were re-visited by various lecturers were amorphous solid dispersions (ASDs), dissolution/permeation interplay, and in vitro methods to predict in vivo biopharmaceutics performance and risk. Topics that repeatedly surfaced across breakout sessions were the following: (1) meaning and assessment of "dissolved drug," particularly of poorly water soluble drug in colloidal environments (e.g., fed conditions, ASDs); (2) potential limitations of a test that employs sink conditions for a poorly water soluble drug; (3) non-compendial methods (e.g., two-stage or multi-stage method, dissolution/permeation methods); (4) non-compendial conditions (e.g., apex vessels, non-sink conditions); and (5) potential benefit of having both a quality control method for batch release and a biopredictive/biorelevant method for biowaiver or bridging scenarios. An identified obstacle to non-compendial methods is the uncertainty of global regulatory acceptance of such methods.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biofarmácia / Absorção Intestinal Limite: Humans Idioma: En Revista: AAPS J Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biofarmácia / Absorção Intestinal Limite: Humans Idioma: En Revista: AAPS J Ano de publicação: 2023 Tipo de documento: Article